Literature DB >> 1728788

Monitoring thrombolytic therapy.

E G Bovill1, R Becker, R P Tracy.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1728788     DOI： 10.1016/0033-0620(92)90022-r

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  2 in total

1.  Inhibition of desmoteplase-induced fibrinolytic activity in vitro.

Authors:  Johannes J M L Hoffmann; Oliver Kops
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

2.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.